Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant

NCT00078533 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infections

Interventions

BIOLOGICAL: CMV CTL infusion

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]